Products

What will AGI do for Bisfenazone?

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C25H29N5O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 3OA32ZIB31, chemically known as 3-(((2,3-dimethyl-5-oxo-1-phenyl-3-pyrzolin-4-yl)amino)methyl)-4-isopropyl-2-methyl-1-phenyl-3-pyrazolin-5-one but generally known as bisfenazone, which bears US NIH Compound Identifier 189866. European Medicines Agency schedules Bisfenazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05851MIG. The term BISFENAZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 29, No. 10 1975, List 15). BISFENAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule bisfenazone under HS 29331190 and SITC 51571. As of Q4 2014, BISFENAZONE remains the US FDA Preferred Term for this commodity. Bisfenazone bears US NLM identifiers UMLS ID C2698516 and NCI Concept Code C77334. SMILES: O=C1N(N(C(C1C(C)C)CNC1C(N(N(C1=O)C1CCCCC1)C)C)C)C1CCCCC1.